D. Boral Capital began coverage on shares of MicroVision (NASDAQ:MVIS – Free Report) in a report published on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $3.00 price objective on the electronics maker’s stock.
Several other research analysts have also recently weighed in on MVIS. Westpark Capital increased their price target on shares of MicroVision from $1.30 to $2.00 and gave the company a “buy” rating in a report on Wednesday, January 22nd. StockNews.com upgraded MicroVision to a “sell” rating in a research note on Friday, December 20th.
Check Out Our Latest Report on MVIS
MicroVision Price Performance
Institutional Trading of MicroVision
Several hedge funds and other institutional investors have recently bought and sold shares of MVIS. Caitlin John LLC acquired a new position in shares of MicroVision during the 4th quarter worth approximately $26,000. Cibc World Markets Corp acquired a new stake in MicroVision during the fourth quarter worth approximately $26,000. Aaron Wealth Advisors LLC acquired a new stake in MicroVision during the third quarter worth approximately $31,000. Warwick Investment Management Inc. bought a new position in MicroVision during the 4th quarter worth $37,000. Finally, Synergy Asset Management LLC raised its holdings in MicroVision by 140.4% in the 4th quarter. Synergy Asset Management LLC now owns 30,252 shares of the electronics maker’s stock valued at $38,000 after acquiring an additional 17,669 shares in the last quarter. Institutional investors and hedge funds own 30.90% of the company’s stock.
MicroVision Company Profile
MicroVision, Inc develops and sells lidar sensors and software used in automotive safety and autonomous driving applications. It offers a suite of light detection and ranging (lidar) sensors and perception; and validation software for automotive OEMs, advanced driver-assistance systems, and autonomous vehicle applications, as well as non-automotive applications including industrial, robotics, and smart infrastructure.
Featured Stories
- Five stocks we like better than MicroVision
- How to Invest in Biotech Stocks
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for MicroVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MicroVision and related companies with MarketBeat.com's FREE daily email newsletter.